Skip to main content
. 2016 Apr 29;8:28–39. doi: 10.1016/j.amsu.2016.04.021

Table 1.

Characteristics of patients and their donors.

Donor age (years) (Mean ± SD) 27.3 ± 6.4
Recipient age (years) (Mean ± SD) 40.9 ± 16.3
Recipient age> 18 years 27 (12.7%)
Donor gender
 Males 139 (65.3%)
 Females 74 (34.7%)
Recipient gender
 Males 183 (85.9%)
 Females 30 (14.1%)
 BMI of donor (Mean ± SD) 25.3 ± 3.4
Child class
 A 19 (8.9%)
 B 67 (31.5%)
 C 127 (59.6%)
 MELD score (<12years) (Mean ± SD) 16 ± 4.2
 PELD score (>12years) (Mean ± SD) 15.2 ± 6.4
 Co morbidity 66 (31%)
 Portal HTN 195 (91.6%)
Bl. Group
 Compatible 67 (31.5%)
 Identical 146 (68.5%)
 Preoperative PVT 27 (12.7%)
Graft type
 Right lobe 178 (83.6%)
 Left lobe 9 (4.2%)
 Left lateral 25 (11.7%)
 Monosegment 1 (0.5%)
HV anastomosis
 Single 153 (71.8%)
 Multiple 60 (28.2%)
PV anastomosis
 Single 197 (92.5%)
 Multiple 16 (7.5%)
HA anastomosis
 Single 204 (95.8%)
 Multiple 9 (4.2%)
 Multiple vascular anastomoses 76 (35.7%)
 Actual graft weight (Mean ± SD) 759.8 ± 239.04
 Actual GRWR (Mean ± SD) 1.2 ± 0.57
 Actual GRWR > 0.8 20 (9.4%)
 SFSS 20 (9.4%)
 Cold ischemia time (min) (Mean ± SD) 69.9 ± 46.4
 Warm ischemia time (min) (Mean ± SD) 49.9 ± 15.6
 Intraoperative blood transfusion (units) 6.03 ± 7
 Intraoperative plasma transfusion (units) 7 ± 8.3
 Duration of operation (hours) (Mean ± SD) 12.5 ± 3.1
 Hospital stay (postoperative) (days) (Mean ± SD) 23.8 ± 16.6
Immunosuppression regimen
 Regimen including FK 176 (82.6%)
 Regimen including cyclosporine 63 (29.6%)
 Regimen including sirolomus 45 (21.1%)
 Post operative acute rejection 44 (20.7%)

BMI: Body mass index, MELD: Model for end stage liver disease, PELD: Pediatric end stage liver disease, Portal HTN: Portal hypertension, PVT: Portal vein thrombosis, GRWR: Graft recipient weight ratio,SFSS: Small for size syndrome.